Qin Xiaoteng, Liu Shangming, Lu Qiulun, Zhang Meng, Jiang Xiuxin, Hu Sanyuan, Li Jingxin, Zhang Cheng, Gao Jiangang, Zhu Min-Sheng, Feil Robert, Li Huashun, Chen Min, Weinstein Lee S, Zhang Yun, Zhang Wencheng
The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Qilu Hospital of Shandong University, Jinan, China.
The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education and Chinese Ministry of Health, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Qilu Hospital of Shandong University, Jinan, China; Key Laboratory of the Ministry of Education for Experimental Teratology, Department of Histology and Embryology, Shandong University School of Medicine, Jinan, China.
Gastroenterology. 2017 Apr;152(5):1114-1125.e5. doi: 10.1053/j.gastro.2016.12.017. Epub 2016 Dec 30.
BACKGROUND & AIMS: The α subunit of the heterotrimeric G stimulatory protein (Gsa), encoded by the guanine nucleotide binding protein, α-stimulating gene (Gnas, in mice), is expressed ubiquitously and mediates receptor-stimulated production of cyclic adenosine monophosphate and activation of the protein kinase A signaling pathway. We investigated the roles of Gsa in vivo in smooth muscle cells of mice.
We performed studies of mice with Cre recombinase-mediated disruption of Gnas in smooth muscle cells (Gsa and SM22-CreER, induced in adult mice by tamoxifen). Intestinal tissues were collected for histologic, biochemical, molecular, cell biology, and physiology analyses. Intestinal function was assessed in mice using the whole-gut transit time test. We compared gene expression patterns of intestinal smooth muscle from mice with vs without disruption of Gnas. Biopsy specimens from ileum of patients with chronic intestinal pseudo-obstruction and age-matched control biopsies were analyzed by immunohistochemistry.
Disruption of Gnas in smooth muscle of mice reduced intestinal motility and led to death within 4 weeks. Tamoxifen-induced disruption of Gnas in adult mice impaired contraction of intestinal smooth muscle and peristalsis. More than 80% of these died within 3 months of tamoxifen exposure, with features of intestinal pseudo-obstruction characterized by chronic intestinal dilation and dysmotility. Gsa deficiency reduced intestinal levels of cyclic adenosine monophosphate and transcriptional activity of the cyclic adenosine monophosphate response element binding protein 1 (CREB1); this resulted in decreased expression of the forkhead box F1 gene (Foxf1) and protein, and contractile proteins, such as myosin heavy chain 11; actin, α2, smooth muscle, aorta; calponin 1; and myosin light chain kinase. We found decreased levels of Gsa, FOXF1, CREB1, and phosphorylated CREB1 proteins in intestinal muscle layers of patients with chronic intestinal pseudo-obstruction, compared with tissues from controls.
Gsa is required for intestinal smooth muscle contraction in mice, and its levels are reduced in ileum biopsies of patients with chronic intestinal pseudo-obstruction. Mice with disruption of Gnas might be used to study human chronic intestinal pseudo-obstruction.
异三聚体G刺激性蛋白(Gsa)的α亚基由鸟嘌呤核苷酸结合蛋白α刺激性基因(在小鼠中为Gnas)编码,广泛表达并介导受体刺激的环磷酸腺苷生成及蛋白激酶A信号通路的激活。我们研究了Gsa在小鼠体内平滑肌细胞中的作用。
我们对通过Cre重组酶介导使平滑肌细胞中Gnas基因缺失的小鼠(Gsa和SM22-CreER,成年小鼠经他莫昔芬诱导)进行了研究。收集肠道组织进行组织学、生化、分子、细胞生物学和生理学分析。使用全肠道转运时间测试评估小鼠的肠道功能。我们比较了Gnas基因有无缺失的小鼠肠道平滑肌的基因表达模式。通过免疫组织化学分析慢性肠道假性梗阻患者回肠活检标本以及年龄匹配的对照活检标本。
小鼠平滑肌中Gnas基因缺失会降低肠道蠕动,并导致在4周内死亡。他莫昔芬诱导成年小鼠Gnas基因缺失会损害肠道平滑肌收缩和蠕动。超过80%的小鼠在接触他莫昔芬后3个月内死亡,表现出肠道假性梗阻的特征,即慢性肠道扩张和运动障碍。Gsa缺乏会降低肠道中环磷酸腺苷水平以及环磷酸腺苷反应元件结合蛋白1(CREB1)的转录活性;这导致叉头框F1基因(Foxf1)及其蛋白以及收缩蛋白如肌球蛋白重链11、肌动蛋白α2、平滑肌主动脉型、钙调蛋白1和肌球蛋白轻链激酶的表达减少。我们发现,与对照组组织相比,慢性肠道假性梗阻患者肠道肌层中Gsa、FOXF1、CREB1和磷酸化CREB1蛋白水平降低。
Gsa是小鼠肠道平滑肌收缩所必需的,慢性肠道假性梗阻患者回肠活检标本中其水平降低。Gnas基因缺失的小鼠可能用于研究人类慢性肠道假性梗阻。